Field Trip Health Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Posts

About This Stock More About This Stock
Psychedelic Compounds-Based Stocks Continue To Decline
Article By: Lorimer Wilson
Monday, May 30, 2022 2:30 AM EST
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share.
In this article: ATAI, MNMD, CMPS, ZYNE, SEEL, GHRS, CYBN, FTRP
Read
Psychedelic Stocks Continue To Decline In May
Article By: Lorimer Wilson
Sunday, May 8, 2022 12:01 AM EST
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.
In this article: ATAI, MNMD, CMPS, ZYNE, GHRS, CYBN, FTRP
Read
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
Article By: Lorimer Wilson
Sunday, March 20, 2022 2:40 AM EST
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD.
In this article: MNMD, CMPS, SEEL, CYBN, FTRP
Read
Marijuana & Psychedelic Compounds-Based Drug Stocks Index Down, Again
Article By: Lorimer Wilson
Sunday, March 6, 2022 11:28 AM EST
Our index of the 13 companies working on drugs based on marijuana and/or psychedelics declined -6% last week and is now -37% YTD.
In this article: ZYNE, CRBP, RVVTF, ALID, FTRP
Read
Psychedelic & Marijuana Drug Stocks Continue To Decline
Article By: Lorimer Wilson
Sunday, February 27, 2022 11:54 AM EST
Thirteen clinical-stage companies with the largest market capitalizations are tracked in our Pure-Play Marijuana (4) and Psychedelic Compounds-Based (9) Drug Stocks Indexes.
In this article: ATAI, MNMD, CMPS, ZYNE, CRBP, GHRS, FTRP
Read

Latest Tweets for $FTRP

No tweets yet!

PARTNER HEADLINES